NCT02138643

Brief Summary

Achalasia is a disorder benign esophageal motor, which is characterized by failure to relax the lower esophageal sphincter ( LES) in response to swallowing associated with lack of peristalsis of the esophageal body. Its most common clinical presentation is dysphagia , and occasionally chest pain , regurgitation , aspiration pneumonia and weight loss , resulting in a large impact on daily activities and quality of life of affected individuals . There is currently considered curative treatment for achalasia , dysphagia relief being the primary therapeutic target and is forced to relax the LES by endoscopy or surgery. Thus , the most commonly used endoscopic treatments are forced dilatation of the cardia and botulinum toxin. Laparoscopic Heller myotomy with antireflux procedure with therapy is considered "gold standard " because of excellent results and minimal invasiveness. Currently , pneumatic dilation and surgical treatment with the Heller myotomy with fundoplication are strongly associated with the best therapeutic options available . In recent years, the possibility of using endoluminal access in the treatment of achalasia patients through the technique originally described as Natural orifices Translumenal Endoscopic Surgery ( NOTES) and continuing advances in the submucosal dissection has enabled the concomitant development of a new approach described as perioral endoscopic myotomy . In 2007, Pasricha et al , described the feasibility of endoscopic esophageal myotomy through a submucosal tunnel initially in an animal model . The first performance of this procedure in humans was described by Inoue et al , in 2010 , introducing the concept of transluminal endoscopic surgery through natural orifices , with the objective of minimizing the trauma and all the stress resulting from open surgical procedure . These authors call the procedure as POEM ( Per Oral Endoscopic myotomy ) .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 16, 2014

Completed
28 days until next milestone

First Posted

Study publicly available on registry

May 14, 2014

Completed
1.7 years until next milestone

Study Start

First participant enrolled

February 1, 2016

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

April 12, 2017

Status Verified

April 1, 2017

Enrollment Period

1.8 years

First QC Date

April 16, 2014

Last Update Submit

April 10, 2017

Conditions

Keywords

AchalasiaMegaesophagusPeropal endoscopic myotomy(POEM)Laparoscopic Heller myotomy

Outcome Measures

Primary Outcomes (1)

  • Remission of symptoms dysphagia.

    Patient selection will last for six months after the beginning of the study. Six months later, conduct additional examinations and randomization. Twelve months after the start of the project will be the completion of endoscopic surgery or laparoscopic surgery for resolution of dysphagia. The measure is a composite.

    12 months after the procedure performed.

Secondary Outcomes (1)

  • Running time of the procedure and hospitalization.

    Starts 12 months after procedure performed.

Study Arms (2)

Endoscopic surgery

ACTIVE COMPARATOR

Patients with symptomatic achalasia confirmed by clinical and laboratory tests, which meet the criteria for inclusion and exclusion. These will be treated with Endoscopic surgery - Peroral endoscopic myotomy (POEM)

Procedure: Endoscopic surgery

Laparoscopic surgery

SHAM COMPARATOR

Patients with symptomatic achalasia confirmed by clinical and laboratory tests, which meet the criteria for inclusion and exclusion. These will be treated with Laparoscopic surgery - Laparoscopic Heller myotomy.

Procedure: Laparoscopic surgery

Interventions

These will be treated with Endoscopic surgery - Peroral endoscopic myotomy (POEM)

Endoscopic surgery

These will be treated with Laparoscopic surgery - Laparoscopic Heller myotomy.

Laparoscopic surgery

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients between 18 and 70 years diagnosed with symptomatic achalasia (dysphagia score ≥ II and Eckardt\> 3) all grades including Rezende classification and Chicago Classification.
  • Patients who agree to participate in the study and signed an informed consent.

You may not qualify if:

  • Treatment (s) prior (s) achalasia.
  • Patients with a history of esophageal, mediastinal and / or gastric surgery (except for gastric perforation).
  • Patients with liver cirrhosis and / or esophageal varices, Barrett's esophagus, esophageal stricture, premalignant or malignant esophageal lesions and coagulopathy.
  • Patients with severe cardiopulmonary disease or other serious illness that results in a high surgical risk.
  • Patients diagnosed with pseudoachalasia
  • Patients diagnosed with diverticulum in the distal esophagus.
  • Pregnancy and lactation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital das Clínicas da FMUSP

São Paulo, São Paulo, 05403000, Brazil

Location

MeSH Terms

Conditions

Deglutition DisordersEsophageal Achalasia

Interventions

EndoscopyLaparoscopy

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic DiseasesEsophageal Motility Disorders

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Paulo Sakai

    Hospital das Clínicas da FMUSP

    PRINCIPAL INVESTIGATOR
  • Eduardo Turiani H de Moura

    Hospital das Clínicas FMUSP

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 16, 2014

First Posted

May 14, 2014

Study Start

February 1, 2016

Primary Completion

November 1, 2017

Study Completion

December 1, 2017

Last Updated

April 12, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

Locations